Latest Articles

Publication Date
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC) - Yahoo Finance

Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC) Yahoo Finance

Published: Aug. 26, 2025, noon
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial - Nature

Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial Nature

Published: Aug. 26, 2025, 11:43 a.m.
Analysis of menstrual effluent uncovers endometriosis-specific cell populations and impaired cellular pathway processes.

Endometriosis is a chronic gynecological disease affecting 1 in 10 reproductive-aged women and is characterized by the ectopic presence of endometrial tissue outside the uterus. The leading hypothesis for disease …

Published: Aug. 26, 2025, midnight
GSK Launches Jemperli for Advanced Endometrial Cancer and Zejula for Ovarian Cancer in India - geneonline.com

GSK Launches Jemperli for Advanced Endometrial Cancer and Zejula for Ovarian Cancer in India geneonline.com

Published: Aug. 25, 2025, 12:03 p.m.
Immunotherapy for High-Grade Endometrial Stromal Sarcoma: A Narrative Review Bridging Molecular Insights to Clinical Translation - Frontiers

Immunotherapy for High-Grade Endometrial Stromal Sarcoma: A Narrative Review Bridging Molecular Insights to Clinical Translation Frontiers

Published: Aug. 25, 2025, 10:47 a.m.
AstraZeneca’s DESTINY-Endometrial01: A New Frontier in Endometrial Cancer Treatment - TipRanks

AstraZeneca’s DESTINY-Endometrial01: A New Frontier in Endometrial Cancer Treatment TipRanks

Published: Aug. 24, 2025, 4:50 p.m.
How transcription factors regulate apoptosis in endometriosis (Review).

Endometriosis (EM) is a common chronic gynaecological disease that affects 10% of women of reproductive age globally. EM is defined as the presence of endometrial glands and stroma in extrauterine …

Published: Aug. 24, 2025, midnight
MMP2/TIMP2 ratio as a measurable indicator for differentiating diffuse adenomyosis, ovarian endometriosis, and their co-existence.

Adenomyosis and endometriosis, two common estrogen-dependent benign gynecological disorders usually present with overlapping symptoms, such as pain and infertility. These two conditions often co-exist and are associated with poor reproductive …

Published: Aug. 24, 2025, midnight
5 Subtle Signs of Endometrial Cancer You Should Never Ignore, According to Doctors - aol.com

5 Subtle Signs of Endometrial Cancer You Should Never Ignore, According to Doctors aol.com

Published: Aug. 23, 2025, 9:57 p.m.
AstraZeneca’s DESTINY-Endometrial01 Study: A New Horizon in Endometrial Cancer Treatment - TipRanks

AstraZeneca’s DESTINY-Endometrial01 Study: A New Horizon in Endometrial Cancer Treatment TipRanks

Published: Aug. 23, 2025, 6:45 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!